The Readout Loud cover image

265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

The Readout Loud

00:00

How New Vaxx Can Be a Bigger Vaccine Player

You have to start by looking at capabilities. What capabilities were needed? And that's exactly where I started with the management team and the board of directors. Once we highlighted that, then you could work on scaling up or down those key capabilities in order to hit our financial targets. Last but not least, we want certain operating profit ratios to put us into the norms for companies that we benchmark ourselves against by 2024. So we had those targets financially organized. We made sure we ring fenced the key capabilities and then scaled within those parameters to achieve their targets. And we did so successfully.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app